Your browser doesn't support javascript.
loading
Chronic Administration of the N-Methyl-D-Aspartate Receptor Antagonist Ketamine Improves Rett Syndrome Phenotype.
Patrizi, Annarita; Picard, Nathalie; Simon, Alex Joseph; Gunner, Georgia; Centofante, Eleonora; Andrews, Nick Arthur; Fagiolini, Michela.
Afiliação
  • Patrizi A; F.M. Kirby Neurobiology Center, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Picard N; F.M. Kirby Neurobiology Center, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Simon AJ; F.M. Kirby Neurobiology Center, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Gunner G; F.M. Kirby Neurobiology Center, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Centofante E; F.M. Kirby Neurobiology Center, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Andrews NA; F.M. Kirby Neurobiology Center, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Fagiolini M; F.M. Kirby Neurobiology Center, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address: michela.fagiolini@childrens.harvard.edu.
Biol Psychiatry ; 79(9): 755-764, 2016 May 01.
Article em En | MEDLINE | ID: mdl-26410354
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome de Rett / Receptores de N-Metil-D-Aspartato / Ketamina Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome de Rett / Receptores de N-Metil-D-Aspartato / Ketamina Idioma: En Ano de publicação: 2016 Tipo de documento: Article